tiprankstipranks
Agile Therapeutics (AGRX)
OTHER OTC:AGRX
US Market

Agile Therapeutics (AGRX) Cash flow

1,500 Followers

Agile Therapeutics Cash Flow

AGRX's free cash flow for Q1 2024 was $-2.48M. For the 2024 fiscal year, AGRX's free cash flow was decreased by $26.50M and operating cash flow was $-2.48M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -12.22M$ -9.58M$ -35.95M$ -65.20M$ -47.31M$ -15.69M
Investing Cash Flow
--$ -133.00K$ 39.46M$ -40.69M$ -98.00K
Financing Cash Flow
$ 11.56M$ 6.89M$ 22.18M$ 30.42M$ 67.98M$ 42.41M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ -45.10M$ 2.56M$ 5.25M$ 19.14M$ 14.46M$ 34.48M
Income Tax Paid Supplemental Data
----$ 0.00$ 0.00
Interest Paid Supplemental Data
$ 326.00K$ 356.00K$ 1.16M$ 2.38M$ 2.10M$ 0.00
Issuance Of Capital Stock
$ 6.51M$ 6.51M$ 21.94M$ 21.08M$ 48.43M$ 42.25M
Issuance Of Debt
$ -2.70M$ -1.35M$ -17.38M-$ 20.00M$ 0.00
Repayment Of Debt
$ -2.70M$ -1.35M$ -17.38M-$ 0.00$ 0.00
Free Cash Flow
$ -12.22M$ -9.58M$ -36.08M$ -65.47M$ -47.66M$ -15.79M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Agile Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis